BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.86 By: Reuters: Company News November 07, 2017 at 16:04 PM EST * Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results Read More >>